Clinical Trial Update: A Study of SI-B001+SI-B003± Chemotherapy in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating SI-B001 plus SI-B003 with or without chemotherapy in locally advanced or metastatic head and neck squamous cell carcinoma;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• SI-B001
• SI-B003

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 1, Phase 2 | Status: RECRUITING